It is crucial to note that within the nanomolar range, 3-aminobenzamide may inhibit mono ADP-ribosylation [39], suggesting a potentially more effective role in the inhibition of PARP activity in retinal degeneration. The gene discussed is PARP1; the disease is retinal degeneration.